Bausch + Lomb Corporation (BLCO) is a publicly traded Healthcare sector company. As of May 20, 2026, BLCO trades at $16.00 with a market cap of $5.74B and a P/E ratio of -26.08. BLCO moved -0.03% today. Year to date, BLCO is -3.57%; over the trailing twelve months it is +37.87%. Its 52-week range spans $10.45 to $21.69. Analyst consensus is neutral with an average price target of $18.60. Rallies surfaces BLCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BLCO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BLCO recently traded at $16.00. Market cap is $5.74B. P/E ratio is -26.08. Revenue is $5.21B.
| Metric | Value |
|---|---|
| Price | $16.00 |
| Market Cap | $5.74B |
| P/E Ratio | -26.08 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.69 |
| 52-Week Low | $10.45 |
| Volume | 310.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.21B |
| Net Income | $-211.00M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.10B | $-352.00M | $-1.02 |
| 2023 | $4.15B | $-248.00M | $-0.74 |
| 2022 | $3.77B | $15.00M | $0.02 |
12 analysts cover BLCO: 0 strong buy, 4 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $18.60.